Repetitive Thoughts in Fibromyalgia: Impact of Rumination on the Emotional and Cognitive Dimensions of Fibromyalgia (PRFM-1)
Dysfunctional chronic diffuse pain syndrome, concerning 2% of the French population, Fibromyalgia (FM) is classified either as a psychological disease or as a somatic disease. This dichotomous reasoning does not lead to a better understanding and does not allow the use or development of new psychological tools of care.
The issue of the proximity between FM and depression highlighted by some authors and the presence of anxious comorbidities may arise at a different level, that of the transdiagnostic approach. Rumination is one of these transdiagnostic processes that are the subject of recent studies and one of the dimensions of which (abstract analytical rumination) is at work in depression and a number of psychopathologies. The investigator therefore wishes to explore the process of rumination and its abstract analytical dimension in FM and to explore its link with the depressive and anxious manifestations frequently associated with this disorder.
|Fibromyalgia||Other: Evaluate the link between an abstract / analytical thinking style and depressive manifestations in FM.|
|Study Design:||Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Other
|Official Title:||Repetitive Thoughts in Fibromyalgia: Impact of Rumination on the Emotional and Cognitive Dimensions of Fibromyalgia|
- Analyze the rate of rumination and depression of a fibromyalgia patient using a questionnaire [ Time Frame: 1 hour ]Analyze the rate of rumination and depression of a fibromyalgia patient using a questionnaire
|Actual Study Start Date:||September 16, 2015|
|Estimated Study Completion Date:||December 30, 2017|
|Estimated Primary Completion Date:||December 30, 2017 (Final data collection date for primary outcome measure)|
|Patient with Fibromyalgia||
Other: Evaluate the link between an abstract / analytical thinking style and depressive manifestations in FM.
Evaluate the link between an abstract / analytical thinking style and depressive manifestations in FM.
Please refer to this study by its ClinicalTrials.gov identifier: NCT03133455
|Contact: Eric SERRA, Dremail@example.com|
|CHU Amiens Picardie||Recruiting|
|Amiens, Picardie, France, 80054|
|Contact: Eric SERRA, Dr +33322668820 firstname.lastname@example.org|